NCT02626104View on ClinicalTrials.gov

Bovine Lactoferrin and Antibiotic-associated Diarrhoea.

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 1, 2017

Study Completion Date

March 1, 2017

Conditions
Antibiotic Associated Diarrhoea
Interventions
DIETARY_SUPPLEMENT

Bovine lactoferrin

The children will be randomly assigned to receive 100 mg of bovine lactoferrin twice a day orally for the whole period of antibiotic therapy.

DIETARY_SUPPLEMENT

Maltodextrin

The children will be randomly assigned to receive 100 mg of placebo - maltodextrin twice a day orally for the whole period of antibiotic therapy.

Trial Locations (1)

01-184

Medical University of Warsaw's Department of Paediatric Gastroenterology and Nutrition, Warsaw

All Listed Sponsors
collaborator

Pharmabest Sp. z o.o.

INDUSTRY

lead

Medical University of Warsaw

OTHER

NCT02626104 - Bovine Lactoferrin and Antibiotic-associated Diarrhoea. | Biotech Hunter | Biotech Hunter